Clinical Trial Update: Efficacy Study of Hydroxychloroquine to Treat High-risk Coronary Artery Disease. [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial assessing the efficacy of hydroxychloroquine in high-risk coronary artery disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Drugs mentioned

• Hydroxychloroquine (hydroxychloroquine)

Snippet

Sponsor: First Affiliated Hospital Xi'an Jiaotong University | Conditions: Coronary Artery Disease | Phase 4 | Status: COMPLETED